Health  Health New Tool Tracks Vaccination and Vaccine Hesitancy Rates Across Geographies, Population Groups Lydia Anderson, Thomas File, Joey Marshall, Kevin McElrath, Zachary Scherer  |  April 14, 2021 Who is getting a COVID-19 vaccine? Who is hesitant about receiving it and why? What state has the highest vaccination or hesitancy rate? The rollout of COVID-19 vaccines has been the subject of extensive news coverage and a new U.S. Census Bureau data visualization tool aims to provide insights into the public’s feelings about COVID-19 vaccines in near real time.

Health Zydus Cadila cuts Remdesivir price to ₹899 Branded as Remdac, it is now more affordable for Covid-19 patients in India Drug major Cadila Healthcare Limited (Zydus Cadila) has revised the price for Remdesivir — branded as Remdac — at ₹899 for 100mg lyophilized injection. RemdacTM was launched in August 2020 at ₹2,800 by Zydus Cadila for Covid-19 patients in India. The prices have been reduced subsequently over the months, and the latest downward revision is further seen benefiting patients in this critical time. The drug today continues to be India’s most economical brand of Remdesivir and a critical drug in the treatment of Covid-19, Zydus said in a statement. Critical drug Sharvil Patel, Managing Director, Cadila Healthcare Limited, said, “Through the course of this pandemic, our efforts have been focused on making therapies accessible and affordable to people. Remdac has been one of the critical drugs in the disease management on Covid and we hope that this price cut will enab